OTCMKTS:COTQF - Cotinga Pharmaceuticals Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.3799 0.00 (0.00 %)
(As of 08/20/2018 04:00 PM ET)
Previous Close$0.3799
Today's Range$0.3799 - $0.3799
52-Week Range$0.10 - $1.40
Average Volume625 shs
Market Capitalization$6.34 million
P/E Ratio-1.19
Dividend YieldN/A
Cotinga Pharmaceuticals logoCotinga Pharmaceuticals Inc., a biopharmaceutical company, develops therapies for the treatment of cancers. The company's lead compound is COTI-2, a clinical stage small molecule targeting p53 proteins, as well as is in the Phase I clinical trial for the treatment of gynecologic cancers, and head and neck squamous cell carcinoma. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. was founded in 1999 and is based in Boston, Massachusetts.

Receive COTQF News and Ratings via Email

Sign-up to receive the latest news and ratings for COTQF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Pharmaceutical preparations


Debt-to-Equity RatioN/A
Current Ratio0.39
Quick Ratio0.39


Trailing P/E Ratio-1.19
Forward P/E Ratio-1.27
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book Value$0.03 per share
Price / Book12.66


EPS (Most Recent Fiscal Year)($0.32)
Net Income$-4,710,000.00
Net MarginsN/A
Return on Equity-1,166.33%
Return on Assets-182.57%


Outstanding Shares16,700,000
Market Cap$6.34 million

Cotinga Pharmaceuticals (OTCMKTS:COTQF) Frequently Asked Questions

What is Cotinga Pharmaceuticals' stock symbol?

Cotinga Pharmaceuticals trades on the OTCMKTS under the ticker symbol "COTQF."

How were Cotinga Pharmaceuticals' earnings last quarter?

Cotinga Pharmaceuticals Inc (OTCMKTS:COTQF) posted its quarterly earnings data on Wednesday, December, 18th. The company reported ($0.01) earnings per share (EPS) for the quarter. View Cotinga Pharmaceuticals' Earnings History.

When is Cotinga Pharmaceuticals' next earnings date?

Cotinga Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Friday, October, 5th 2018. View Earnings Estimates for Cotinga Pharmaceuticals.

Who are some of Cotinga Pharmaceuticals' key competitors?

Who are Cotinga Pharmaceuticals' key executives?

Cotinga Pharmaceuticals' management team includes the folowing people:
  • Ms. Alison D. Silva, Chief Exec. Officer, Pres and Director
  • Mr. Eugene Francis Kelly, Chief Financial Officer
  • Ms. Debi Sanderson MBA, Director of Resourcing & Operations
  • Dr. Richard T. Ho, Chief Scientific Officer (Age 55)
  • Mr. Paul Papi, VP of Investor Relations

Has Cotinga Pharmaceuticals been receiving favorable news coverage?

News coverage about COTQF stock has trended somewhat positive on Monday, Accern reports. The research firm identifies positive and negative media coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Cotinga Pharmaceuticals earned a news and rumor sentiment score of 0.11 on Accern's scale. They also gave news headlines about the company an impact score of 45.59 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future. View Recent Headlines for Cotinga Pharmaceuticals.

How do I buy shares of Cotinga Pharmaceuticals?

Shares of COTQF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cotinga Pharmaceuticals' stock price today?

One share of COTQF stock can currently be purchased for approximately $0.3799.

How big of a company is Cotinga Pharmaceuticals?

Cotinga Pharmaceuticals has a market capitalization of $6.34 million. The company earns $-4,710,000.00 in net income (profit) each year or ($0.32) on an earnings per share basis.

How can I contact Cotinga Pharmaceuticals?

Cotinga Pharmaceuticals' mailing address is 700 Collip Circle Suite 213, London A6, N6G 4X8. The company can be reached via phone at 519-858-5157 or via email at [email protected]

MarketBeat Community Rating for Cotinga Pharmaceuticals (OTCMKTS COTQF)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  47 (Vote Outperform)
Underperform Votes:  87 (Vote Underperform)
Total Votes:  134
MarketBeat's community ratings are surveys of what our community members think about Cotinga Pharmaceuticals and other stocks. Vote "Outperform" if you believe COTQF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe COTQF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/20/2018 by MarketBeat.com Staff

Featured Article: Technical Analysis

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel